Myo-inositol metabolism in appropriately grown and growth-restricted fetuses: a proton magnetic resonance spectroscopy study

详细信息    查看全文

• 作者：Lisa Story ; Mellisa S. Damodaram ; Veena Supramaniam ; Joanna M. Allsop ; Amy Mcguinness ; Abhilasha Patel ; Marzena Wylezinska ; Sailesh Kumar ; Mary A. Rutherford
• 关键词：Fetal growth restriction ; Brain ; Magnetic resonance spectroscopy
• 刊名：European Journal of Obstetrics and Gynecology and Reproductive Biology
• 出版年：2013
• 出版时间：September, 2013
• 年：2013
• 卷：170
• 期：1
• 页码：77-81
• 全文大小：903 K

文摘

Objective

Myo-inositol (Myo-ins) is a marker of neuroglial cells, being present in the astrocytes of brain tissue, but also functions as an osmolyte. Numbers of astrocytes are known to increase following injury to the brain. Growth-restricted fetuses are at increased risk of later neurodevelopmental impairments even in the absence of overt lesions and despite preserved/increased cerebral blood flow. This study aims to investigate brain Myo-ins metabolism in fetuses with intrauterine growth restriction (IUGR) and evidence of cerebral redistribution using magnetic resonance spectroscopy (MRS) at a short echo time.

Study design

Biometry and Doppler assessment of blood flow was assessed using ultrasound in 28 fetuses with IUGR and 47 appropriately grown control subjects. MRI was used to exclude overt brain injury. Proton magnetic resonance spectroscopy of the fetal brain was then performed at an echo time of 42 ms to examine the Myo-ins:Choline (Cho), Myo-ins:Creatine (Cr) and Cho:Cr ratios.

Results

No alterations in brain Myo-ins:Cho, Myo-ins:Cr or Cho:Cr ratios were detected between appropriately grown and growth restricted fetuses.

Conclusions

IUGR is not associated with a measureable difference in brain myo-inositol ratios. This may be due to the protective effects of preserved cerebral blood flow in growth restriction and comparable astrocyte numbers when compared to controls.